What is a protocol on this site?

A dosing schedule with its source attached. There are 10 of them. Each one gives the amount, how often, how it is taken and for how long, exactly as the source reports them. Then it says what was measured, what happened, and what the schedule cannot tell you. The badge on every card says where it came from before you read a single number.

What is a protocol on this site not?

It is not a recommendation, and nothing here is dosing advice. It is not a schedule for you, because none of these were designed around one person. It is not a claim that a pattern works. The community entries record what people say they do, and a report is not a result.

Why is the kind badge the first thing on every card?

Because a schedule from a large final-stage study and a schedule from a seller's dosing guide are not the same kind of thing. Laying them out as if they were is the central dishonesty of this field. 5 of the 10 entries here carry a PubMed or ClinicalTrials record you can open yourself. The rest say plainly what they are.

Why does every entry have a limits section?

Because the schedule is the easy part and the limit is the useful part. A study schedule that produced a real number was still run in a group of people that may not include someone like you. It ran for a length of time that says nothing about what comes after. And it measured something that may not be the thing you care about. Every entry must have a limits section, and it is never empty.

Do any of these tell me what dose to take?

No. Several of them record what a study gave people and what happened. That is a fact about that study, not an instruction to you. Several record what people say they do, which is not even that. Anything you would act on belongs with a doctor who knows your situation. This site sells nothing and asks you for nothing.

Protocols · 10 schedules

Every schedule here says who ran it before it says a number

A protocol on this site is a dosing schedule with its source attached. It gives the amount, how often, how it is taken and for how long, exactly as the source reports them. Then it says what was actually measured, what happened, and what the schedule cannot tell you. Of the 10 here, 5 come from registered studies and carry a PubMed or ClinicalTrials record you can open yourself. The others come from a named clinic, from forum patterns, or from the owner, and each one says so up front.

None of this is advice, and nothing here is a dose for you. 2 of the 10 entries measured nothing at all, and the entry says so instead of leaving you to work it out. Every protocol must have a limits section, and it is never empty. The schedule is the easy part. The limit is the part worth reading.

Plate 32

Schedule catalog

Templates, not advice

Schedules

template

Not a prescription

Dated schedules for tracking. For learning only. Not a dose we recommend.

Protocols catalogued: 10; across 10 compounds
From a registered study: 5 of 10; each with a record you can open and check
Measured nothing: 2 of 10; and the entry says so rather than implying otherwise

Trial protocol

5 entries

The schedule a registered study in people actually used, taken from the paper and the study's public registration, not from a label summary. Every one links a PubMed or ClinicalTrials record you can open.

Semaglutide 2.4 mg weekly, the STEP 1 escalation

Weight loss in adults who are overweight or have obesity, and do not have diabetes

Trial protocol

Amount: 2.4 mg as the ongoing dose, reached by stepping up over 16 weeks
How often: Once weekly
How it is taken: Shot under the skin
How long: 68 weeks including the step-up

What was measured: The main things measured: how much body weight changed, in percent, from the start to week 68, and how many people lost at least 5 percent. Also measured: weight in kilograms, heart and blood sugar risk factors, and how well people said they could move and function.
What it cannot tell you: Everyone also got diet and exercise coaching, so the schedule was never tested on its own. The drug cannot be separated from the program around it. People with diabetes were left out, so the numbers do not carry over to them. 68 weeks says nothing about year three. The study measured weight, not the health problems underneath it that people actually care about. The step-up exists because the drug is hard to handle, and 4.5 percent still stopped for gut side effects, with a study team watching over them.

SemaglutideStrongRead it in full

Not advice. This is a record of a schedule, not a dose for you.

Tirzepatide weekly, the SURMOUNT-1 escalation

Weight loss in adults with obesity or overweight and no diabetes

Trial protocol

Amount: 5 mg, 10 mg or 15 mg as the ongoing dose, assigned by chance
How often: Once weekly
How it is taken: Shot under the skin
How long: 72 weeks in the main treatment period

What was measured: The main things measured: how much body weight changed, in percent, by week 72, and how many people lost at least 5 percent. Also measured: fat and muscle, waist size, and heart and blood sugar numbers.
What it cannot tell you: Weight was what it measured. This study did not measure heart attacks, strokes or deaths. Tirzepatide's later approval for heart health rests on a different study in different people. Everyone here had a diet and exercise program and a study team watching over them, and people with diabetes were left out. The step-up is there to make the drug easier to handle, not a goal to reach. Someone who cannot stay on the assigned ongoing dose has no number in this table that fits them.

TirzepatideStrongRead it in full

Not advice. This is a record of a schedule, not a dose for you.

Retatrutide step-up, the early study plan behind TRIUMPH-1

Weight loss with an experimental drug that acts on three gut hormone signals

Trial protocol

Amount: 1 mg, 4 mg, 8 mg or 12 mg as the ongoing dose, from a starting dose of either 2 mg or 4 mg
How often: Once weekly
How it is taken: Shot under the skin
How long: 48 weeks in the mid-stage study. The large final-stage TRIUMPH-1 ran 80 weeks, plus a further 24 week extension.

What was measured: The main thing measured: how much body weight changed, in percent, from the start to 24 weeks. Also measured: the change at 48 weeks, and how many people lost 5, 10 and 15 percent. Safety, gut side effects and heart rate were checked.
What it cannot tell you: Retatrutide is not approved anywhere, for anything. Every milligram figure above comes from a mid-stage study of 338 people whose main result was at 24 weeks. Doses at that stage are picked to find the range, not to be the right dose. The registry does not publish the final-stage doses, so nobody outside Lilly can say what the study that reported 28.3 percent actually gave. Heart rate rose with the dose. Anything sold as retatrutide is not made by Lilly, and nothing checks what it is or what is in it.

RetatrutideStrongRead it in full

Not advice. This is a record of a schedule, not a dose for you.

Tesamorelin 2 mg daily, the pivotal lipodystrophy schedule

Cut deep belly fat in people with HIV whose treatment made fat build up there

Trial protocol

Amount: 2 mg
How often: Once daily
How it is taken: Shot under the skin
How long: 26 weeks

What was measured: The main thing measured: the change in deep belly fat on a CT scan, in percent, from the start. Also measured: triglycerides, total cholesterol compared with HDL cholesterol, IGF-1, how people felt about their body, and blood sugar and insulin.
What it cannot tell you: The people studied had HIV, and their HIV drugs had made fat build up in their belly. That is not the same as a person who wants a flatter stomach. What it measured was fat on a CT scan, so nothing here tells you about heart attacks, diabetes or how long anyone lived. The study ran 26 weeks and says nothing about what happens after that, or when the drug stops. IGF-1 rising 81 percent shows the growth hormone system responded. It is not a benefit in itself.

TesamorelinStrongRead it in full

Not advice. This is a record of a schedule, not a dose for you.

BPC-157 80 mg enema, the Croatian ulcerative colitis study

Calm mild to moderate ulcerative colitis, a bowel disease

Trial protocol

Amount: 80 mg
How often: Once daily
How it is taken: Enema (liquid put into the rectum)
How long: Two weeks

What was measured: The change in a standard colitis symptom score over two weeks. Nothing about tendon, ligament, joint or muscle healing was measured, because this was a bowel study.
What it cannot tell you: In the one study of BPC-157 in people that used a dummy treatment, people on the dummy did about as well. It tested an 80 mg enema for ulcerative colitis. That is not the way it is given, the dose, the problem or the length of use of anyone buying BPC-157 for a tendon. It was never published in full, so what is here is an FDA reviewer's account of a conference summary, not a report anyone can read. No study has ever given BPC-157 as a shot under the skin for an injury and reported a result. The first one, a 120 person mid-stage study in hamstring strain, began signing people up in February 2026 and expects its main results in February 2027.

BPC-157LimitedRead it in full

Not advice. This is a record of a schedule, not a dose for you.

Clinic report

1 entry

What a named clinic said it did, in a published write-up. These describe what the clinic did. They do not show that it worked, and none of them compared against a group that did not get it.

BPC-157 injected into the knee, one Florida clinic

Knee pain from several different causes

Clinic report

Amount: 2 to 4 mg
How often: One or two doses in total
How it is taken: A shot into the knee joint, given by a doctor
How long: A single course, with a follow-up phone call 6 to 12 months later

What was measured: Nothing was measured as it happened. Patients were phoned 6 to 12 months later and asked, from memory, whether their knee pain had improved. There was no proper pain scale, no scans, no starting score, and no group that went without it to compare against.
What it cannot tell you: A phone survey, after the fact, of 17 people from one clinic cannot show that anything worked. With no comparison group, there is nothing to measure the improvement against. There is no way to separate the peptide from the shot itself, from six to twelve months passing, or from a patient wanting to give their doctor a good answer. Remembered pain is not a measurement. The same clinic group wrote the other BPC-157 reports in people that had no comparison group, so the small human record for this compound mostly comes from one source.

BPC-157LimitedRead it in full

Not advice. This is a record of a schedule, not a dose for you.

Community pattern

3 entries

Patterns that get passed around on peptide forums and in sellers' dosing guides. Nobody measured anything properly in any of these. They are listed here as reports, not findings.

BPC-157 with TB-500, the pattern that circulates

Recovery from a muscle, tendon or ligament injury

Community pattern

Amount: Two patterns keep coming up. An even one at about 250 mcg of each. And a heavier one at 250 to 500 mcg of BPC-157 daily with 2 to 2.5 mg of TB-500 twice a week.
How often: BPC-157 once or twice daily. TB-500 either alongside it daily or twice weekly.
How it is taken: A shot under the skin, often described as given near the injury
How long: Usually described as four to eight weeks, sometimes longer

What was measured: Nothing. No blood test, no scans, no strength or movement test, and no proper pain scale. What gets reported back is how somebody says their injury felt.
What it cannot tell you: Nobody measured anything. There is no study of BPC-157 with TB-500 in people, in any mix, at any dose, for any injury. The amounts above come from nothing but repetition. Neither compound has a proven dose for people. Lab tests of products sold as TB-500 found a small piece made of seven amino acids, not full thymosin beta 4. So half of this pattern may not be the molecule it is named after. An injury that was going to heal anyway heals during the four to eight weeks someone runs this. And recovery that people report about themselves, from people who chose to post, is the weakest evidence there is.

BPC-157LimitedTB-500PreliminaryRead it in full

Not advice. This is a record of a schedule, not a dose for you.

CJC-1295 with ipamorelin, the night time pattern

Raise growth hormone for sleep, recovery, and more muscle and less fat

Community pattern

Amount: Usually reported as 100 mcg of each
How often: Once at night, often described as five nights on and two off
How it is taken: A shot under the skin, usually on an empty stomach
How long: Usually described in blocks of eight to twelve weeks

What was measured: Some people check IGF-1, a growth hormone blood marker, before and after. Most check nothing. Sleep, recovery, and muscle and fat are reported by feel. Almost nobody gets a body scan.
What it cannot tell you: Both halves push the same growth hormone system, so nothing here can tell you which one did anything. The pair has never been tested as a pair in a study. Most of what is sold as CJC-1295 without DAC is really mod GRF 1-29, so the name on the vial may not match what is inside. A rise in IGF-1 is just a blood number. It says the system responded, not that anything you wanted happened to your body. Nobody here measured muscle and fat with a scan, everyone knew what they were taking, and sleeping better in the first weeks of anything new is the oldest trap there is.

CJC-1295LimitedIpamorelinModerateRead it in full

Not advice. This is a record of a schedule, not a dose for you.

The slow GLP-1 step-up, as people actually do it

Reach a GLP-1 dose you can handle without the gut side effects, or stay below the label dose on purpose

Community pattern

Amount: Pharmacy-mixed (compounded) vials, drawn to amounts the pens do not offer. People describe starting as low as 0.25 mg to 1.5 mg of tirzepatide a week, against the 2.5 mg the label starts at.
How often: Once weekly
How it is taken: A shot under the skin, drawn from a pharmacy-mixed vial instead of a fixed-dose pen
How long: Each step held for four weeks or longer, and often held at a low dose for good instead of stepping up at all

What was measured: Body weight on a home scale, and how the person feels. Almost nobody doing this measures any of the things the studies measured. And nobody is checking what dose actually reached them from a drawn vial.
What it cannot tell you: Every result that makes people want a GLP-1 came from a study that stepped up to a full ongoing dose and stayed there. Someone who stops at a fraction of that dose has no number to expect. Nobody has tested below-label doses against the label schedule. So nobody knows whether a slower ramp cuts nausea overall, or just pushes it later. Pharmacy-mixed vials are not checked for what is in them the way an approved pen is. And drawing a dose from a vial is less exact than clicking a pen. Nobody is keeping watch on any of this.

TirzepatideStrongSemaglutideStrongRead it in full

Not advice. This is a record of a schedule, not a dose for you.

Owner position

1 entry

The owner's own stated view, signed, with the limit he already states on the site attached. Results stay empty until his own numbers exist.

Splitting a weekly testosterone dose, the owner's position

Smooth out the highs and lows of a short-acting testosterone shot without changing the total dose

Owner position

Amount: The same prescribed weekly total, divided. Splitting is not a reason to take more.
How often: Two or three smaller shots a week instead of one a week, or instead of one every two weeks
How it is taken: However the prescription says, into the muscle or under the skin
How long: Ongoing. This is a schedule rather than a course.

What was measured: Total testosterone, free testosterone, usable (bioavailable) testosterone and SHBG, a protein that binds testosterone. Two blood draws, eighteen months apart. The first was before any testosterone was prescribed. The second was after starting 100 mg of testosterone cypionate a week. Neither recorded how long after the last shot the blood was drawn. Neither measured estrogen (estradiol) or red blood cell level (hematocrit). That is the gap that matters most here, and it is repeated in the limits below.
What it cannot tell you: The owner's own numbers are now on this page, and they do not test the view this page is about. The two draws sit on either side of starting treatment. So they show that testosterone replacement raised his testosterone, which nobody doubted. They have no comparison with one shot a week, no recorded time since the last shot, no estrogen and no hematocrit. Timing is the whole argument for splitting, so a level with no time attached cannot back it up or knock it down. No study has compared split doses with one weekly shot and tracked symptoms, either. So the view rests on how long the drug lasts in the body plus practice guidance, not on studies. It says nothing about the right total dose. One person's numbers are one story with a lab report attached. They are published here because this site asks everyone else to show their evidence, not because they settle anything.

TestosteroneModerateTestosterone cypionateModerateRead it in full

Not advice. This is a record of a schedule, not a dose for you.

Questions people ask about this

What is a protocol on this site?: A dosing schedule with its source attached. There are 10 of them. Each one gives the amount, how often, how it is taken and for how long, exactly as the source reports them. Then it says what was measured, what happened, and what the schedule cannot tell you. The badge on every card says where it came from before you read a single number.
What is a protocol on this site not?: It is not a recommendation, and nothing here is dosing advice. It is not a schedule for you, because none of these were designed around one person. It is not a claim that a pattern works. The community entries record what people say they do, and a report is not a result.
Why is the kind badge the first thing on every card?: Because a schedule from a large final-stage study and a schedule from a seller's dosing guide are not the same kind of thing. Laying them out as if they were is the central dishonesty of this field. 5 of the 10 entries here carry a PubMed or ClinicalTrials record you can open yourself. The rest say plainly what they are.
Why does every entry have a limits section?: Because the schedule is the easy part and the limit is the useful part. A study schedule that produced a real number was still run in a group of people that may not include someone like you. It ran for a length of time that says nothing about what comes after. And it measured something that may not be the thing you care about. Every entry must have a limits section, and it is never empty.
Do any of these tell me what dose to take?: No. Several of them record what a study gave people and what happened. That is a fact about that study, not an instruction to you. Several record what people say they do, which is not even that. Anything you would act on belongs with a doctor who knows your situation. This site sells nothing and asks you for nothing.